i
2022 National Healthcare Safety Network antimicrobial use option report
-
November 2023
[PDF-1.97 MB]
Details:
-
Corporate Authors:
-
Description:The 2022 NHSN AU Option Report summarizes SAAR distributions and antimicrobial use within each SAAR antimicrobial agent category among adult, pediatric, and neonatal patient care locations (specified in Table 1). The report includes data from acute care hospitals that reported at least nine months of data in 2022 from SAAR locations: 2,007 hospitals reported from eligible adult SAAR locations, 369 reported from pediatric SAAR locations, and 760 reported from neonatal SAAR locations. The distributions of SAARs inform stewardship efforts by showing hospitals how their SAARs compare with the national distribution and local, state, and territorial health departments how their SAARs compare with others. Hospitals can consider the distributions to set facility-specific targets when using the NHSN Targeted Assessment for Antimicrobial Stewardship (TAS) Strategy. The percentage of AU by class and drug within a SAAR antimicrobial agent category provides insight into prescribing practices across different patient care locations, such as medical critical care units (also known as intensive care units, or ICUs) compared to medical wards. Facilities may evaluate usage patterns in the context of their local treatment guidelines, penicillin allergy algorithms, antimicrobial resistance rates, and formulary. For more information and resources related to TAS, refer to the TAS Guide.
Suggested citation: CDC. 2022 National Healthcare Safety Network Antimicrobial Use Option Report. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2023. Available at: https://www.cdc.gov/nhsn/pdfs/datastat/2022-AU-Report-508.pdf.
2022-au-report-508.pdf
-
Subjects:
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
